...
首页> 外文期刊>Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology >Does progesterone supplementation improve pregnancy rates in clomiphene citrate and intrauterine insemination treatment cycles?
【24h】

Does progesterone supplementation improve pregnancy rates in clomiphene citrate and intrauterine insemination treatment cycles?

机译:补充孕激素是否可以提高柠檬酸克罗米芬和宫内授精治疗周期的妊娠率?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aim: To investigate the effect of empiric use of luteal phase progesterone supplementation to improve endometrial receptivity in women undergoing treatment with clomiphene citrate incombination with intrauterine insemination (CC-IUI).Design: Retrospective cohort analysis.Setting: University fertility center. Patients: 426 CC-IUI cycles from 292 patients with unexplained infertility.Interventions: Patients were treated with micronized intravaginal progesterone 100mg twice daily beginning approximately three days after CC-IUI.Main outcome measure(s): Clinical pregnancy per initiated cycle as defined by presence of fetal heart rate on ultrasound.Results: Clinical pregnancy rate was higher in patients receiving luteal phase support comparedto patients not receiving luteal phase support (odds ratio: 2.04; 95% confidence interval: 1.01-4.14) after adjusting for all factors in the analysis using a multivariate logistic regression model.Age at the start of the cycle, BMI and CC dose were not shown to have an effect on clinicalpregnancy rates. Patients with endometrial lining (EML) thickness 6-8 mm and >8mm hadincreased clinical pregnancy rates compared to EML <6mm independent of luteal phaseprogesterone use. Patients who appear to receive the greatest benefit of progesteronesupplementation are in the 6-8 mm EML cohort.Conclusions: Luteal phase progesterone supplementation in CC-IUI cycles can improveendometrial receptivity as judged by the improved clinical pregnancy rates as the primaryoutcome.
机译:目的:探讨黄体期黄体酮补充剂对柠檬酸克罗米芬联合宫腔内人工授精(CC-IUI)治疗的妇女改善子宫内膜容受性的作用设计:回顾性队列分析背景:大学生育中心。患者:来自292名原因不明的不育症患者的426个CC-IUI周期干预措施:在CC-IUI后约三天开始,每天两次用微粒化的100mg阴道内孕激素治疗患者。主要结局指标:结果:经校正所有因素后,接受黄体期支持的患者的临床妊娠率高于未接受黄体期支持的患者(几率:2.04; 95%置信区间:1.01-4.14)。使用多元logistic回归模型进行分析。在周期开始时,未显示BMI和CC剂量对临床妊娠率有影响。与黄体期孕酮的使用无关,子宫内膜衬层(EML)厚度为6-8 mm且> 8mm的患者与EML <6mm相比,其临床妊娠率增加。结论:在6-8 mm EML队列中,似乎最可能接受补充孕激素的患者。结论:CC-IUI周期中补充黄体期孕酮可以改善子宫内膜的接受性,这是通过改善临床妊娠率来判断的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号